Cory S. Freedland serves as Executive at Neurogene Inc., where they oversee executive responsibilities. Since joining the company, Cory S. Freedland has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 20, 2026 involved receiving (via award) 12,050 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 20, 2026 | NGNE | $0 | Award | 12,050 | $N/A | Discretionary |
Cory S. Freedland currently holds 12,050 shares of Neurogene Inc. (NGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cory S. Freedland has been a net neutral trader of NGNE stock. They have purchased $0 and sold $0 worth of shares.
Cory S. Freedland's most recent insider trade was on Feb 20, 2026, when they sold 12,050 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted